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Purpose: En face observation of corneal endothelial cells (ECs) using flat-mounted whole corneas is theoretically much
more informative than observation of cross-sections that show only a few cells. Nevertheless, it is not widespread for
immunolocalization (IL) of proteins, probably because the endothelium, a superficial monolayer, behaves neither like a
tissue in immunohistochemistry (IHC) nor like a cell culture in immunocytochemistry (ICC). In our study we optimized
IL for ECs of flat-mounted human corneas to study the expression of cell cycle-related proteins.
Methods: We systematically screened 15 fixation and five antigen retrieval (AR) methods on 118 human fresh or stored
corneas (organ culture at 31 °C), followed by conventional immunofluorescence labeling. First, in an attempt to define a
universal protocol, we selected combinations able to correctly localize four proteins that are perfectly defined in ECs
(zonula occludens-1 [ZO-1] and actin) or ubiquitous (heterogeneous nuclear ribonucleoprotein L [hnRNP L] and histone
H3). Second, we screened protocols adapted to the revelation of 9 cell cycle proteins: Ki67, proliferating cell nuclear
antigen (PCNA), minichromosome maintenance protein 2 (MCM2), cyclin D1, cyclin E, cyclin A, p16Ink4a, p21Cip1 and
p27Kip1. Primary antibody controls (positive controls) were performed on both epithelial cells of the same, simultaneously-
stained whole corneas, and by ICC on human ECs in in vitro non-confluent cultures. Both controls are known to contain
proliferating cells. IL efficiency was evaluated by two observers in a masked fashion. Correct localization at optical
microscopy level in ECs was define as clear labeling with no background, homogeneous staining, agreement with previous
works on ECs and/or protein functions, as well as a meaningful IL in proliferating cells of both controls.
Results: The common fixation with 4% formaldehyde (gold standard for IHC) failed to reveal 12 of the 13 proteins. In
contrast, they were all revealed using either 0.5% formaldehyde at room temperature (RT) during 30 min alone or followed
by AR with sodium dodecyl sulfate or trypsin, or pure methanol for 30 min at RT. Individual optimization was nevertheless
often required to optimize the labeling. Ki67 was absent in both fresh and stored corneas, whereas PCNA was found in
the nucleus, and MCM2 in the cytoplasm, of all ECs. Cyclin D1 was found in the cytoplasm in a paranuclear pattern much
more visible after corneal storage. Cyclin E and cyclin A were respectively nuclear and cytoplasmic, unmodified by
storage. P21 was not found in ECs with three different antibodies. P16 and p27 were exclusively nuclear, unmodified by
storage.
Conclusions: IL in ECs of flat-mounted whole human corneas requires a specific sample preparation, especially to avoid
overfixation with aldehydes that probably easily masks epitopes. En face observation allows easy analysis of labeling
pattern within the endothelial layer and clear subcellular localization, neither of which had previously been described for
PCNA, MCM2, or cyclin D1.
The  corneal  endothelium  functions  as  a  permeability
barrier that restricts the movement of water and solutes into
the hydrophilic stroma to control corneal transparency [1]. It
is composed of a monolayer of flat (approximately 5 μm)
tessellated joint cells forming a mosaic of mainly hexagonal
elements (Figure 1). In the adult human, the proliferative
capacities of endothelial cells (ECs) are practically nil and
cannot offset cell losses in physiologic or pathological cases.
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Indeed,  no  increase  in  EC  number  has  been  clinically
documented. Although in physiologic conditions the number
of ECs decreases very slowly, by about 0.6% per year during
adulthood [2,3], this pace accelerates dramatically in several
corneal diseases (mainly Fuchs’ dystrophy, the most frequent
endothelial  primary  dystrophy)  and  after  accidental  or
surgical  traumatisms:  endothelial  cell  density  (ECD)  falls
below a threshold of 300 to 500 cells/mm2 (depending on the
kinetics of loss) and an irreversible corneal edema occurs,
causing permanent visual loss. During corneal storage by eye
banks, be it in short-term cold storage at 4 °C in Optisol or in
long-term storage at 31 °C to 34 °C in organ culture (OC)
media, EC loss also accelerates strongly, causing a decrease
in graft quality. In the past two decades Joyce and colleagues
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3494have highlighted, mainly based on proteomic studies, that
adult ECs in vivo are arrested in the G1 phase of the cell cycle
(reviewed  in  [4]).  However  in  parallel,  they  also
demonstrated,  with  other,  that  ECs  retain  proliferative
capacity  [5]  even  in  the  elderly,  but  with  an  age-related
decrease [6,7]. Primary EC cultures from adult donors of all
ages can also be routinely obtained in vitro [8].
Stimulation and control of EC proliferation would have
high therapeutic impact, making it possible to increase ECD
directly in vivo in patients with low ECD and to improve the
quantity and quality of donor corneas by increasing ECD ex
vivo during storage in eye banks, or by facilitating large-scale
development  of  bioengineered  endothelial  grafts.
Identification of the proteins involved in cell cycle arrest is
key to these future EC therapies.
Figure 1. Hoechst 33342 nuclei staining and tight-junction immunostaining with zonula occludens-1 (ZO-1) antibody illustrate the differences
between conventional immunohistochemistry on a corneal cross-section where only a few endothelial cells are partially visible, and en face
view showing a wide field of intact cells. Original magnification 40×. Bar 10 μm.
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3495Immunolocalization (IL) of proteins has been previously
used, as a basic tool, on corneal endothelium. Generally, ECs
can be observed either on corneal cross-sections or on flat-
mounts,  as  the  EC  monolayer  of  300,000  to  400,000
tessellated cells on the innermost surface of the cornea is
easily  visible  by  en  face  observation.  Although  standard
immunohistochemistry (IHC) on corneal cross-sections is the
prevalent method in the literature, it allows visualization of
only  a  few  cells,  not  a  complete  view  of  the  unmodified
endothelium (Figure 1). Moreover, it does not always give a
clear  subcellular  localization  of  proteins  of  interest,  a
condition  required  for  a  proper  interpretation  [9].  On  the
contrary, IL on flat-mounted corneas theoretically appears far
more informative. It gives access to the whole intact tissue
with a possibility to detect regional differences in expression
patterns (for example a centripetal gradient) as well as to
detect rare isolated cells among an apparently homogeneous
cell population. Nevertheless, to date it has been used in very
few studies and for few proteins. Moreover, in the only paper
reporting the use of both cross-sections and flat-mounts with
the same antibodies, immunostaining was not identical, with
generally fewer positive results on flat-mounts [10].
In  the  present  study,  we  systematically  screened
immunostaining protocols to select those able to correctly
reveal proteins in ECs of intact flat-mounted corneas. Fixation
and antigen retrieval (AR) are two fundamental steps in all
immunostaining  processes.  They  strongly  influence  the
ability  of  specific  antibodies  to  recognize  their  targets
(retention of antigenicity) while offering good preservation of
ultrastructure.  Cross-linking  fixatives  (aldehydes)  act  by
creating covalent chemical bonds between proteins, mainly
between  lysine  residues  [11].  They  also  anchor  soluble
proteins  to  the  cytoskeleton.  Formaldehyde  is  the  most
common fixative in histology. Four percent formaldehyde
(equivalent to the neutral-buffered formalin (10%) used for
clinical pathology) appears as a gold standard in most studies,
including those on corneal endothelium. Precipitating, also
called denaturing, fixatives (ethanol, methanol, and acetone)
reduce the solubility of proteins and disrupt the hydrophobic
interactions involved in the tertiary structure of proteins. They
are commonly used for immunocytochemistry (ICC), alone or
in  combination.  Metallic  fixatives,  which  denature  the
proteins  and  create  weak  bonds  between  them,  are  rarely
employed  alone  in  ICC  or  IHC.  Nevertheless,  HgCl2  or
ZnCl2  containing  formaldehyde  solutions  improve  nuclear
morphology with various effects on antigenicity [12]. AR,
either by heating in specific buffers, enzymatic digestion or
chemical reagents, helps unmask certain hidden epitopes. It
can be helpful or even crucial during IHC of formalin-fixed
paraffin-embedded  tissues  [13].  Heat-induced  antigen
retrieval (HIAR), known to hydrolyse protein cross-linking
that occurred during aldehyde fixation (but not only [14]), is
the most common AR technique [15], but enzymatic digestion
by trypsin that cleaves peptide chains mainly at the carboxyl
side of lysine, and protein denaturants like sodium dodecyl
sulfate (SDS) and urea, have also been used.
In this study, we present optimization of fixation and AR
methods for ECs of flat-mounted whole human corneas, and
results obtained on a very large series of corneas for IL of
proteins involved in cell cycle control.
METHODS
Human corneas: Corneas were retrieved by in situ excision,
the  routine  method  for  clinical  use.  Fifty  corneas  were
obtained from the Department of Anatomy of the Faculty of
Medicine of Saint-Etienne (body donation to science). Bodies
were refrigerated at 4 °C in conditions comparable with those
used for donation for clinical use. Donor age (mean±standard
deviation, range, median) was 81±11 years, (46 to 99, 82), and
time from death to procurement was 27±14 h (7 to 48, 23).
Corneas  were  fixed  immediately  after  procurement  and
further processed (group 1 of fresh corneas). Seventy-six other
corneas were obtained from the Eye Bank of Saint-Etienne,
Saint-Etienne, France. Corneas were not suitable for corneal
graft because of inconclusive donor serologies, but had a
normal endothelium. Corneas were stored in OC at 31 °C for
25±9 days (7 to 35, 27) in CorneaMax medium (Eurobio, Les
Ulis,  France)  before  fixation  and  processing  for
immunostainings (group 2 of stored corneas). Donor age was
73±12 years (42 to 94, 76), and death-to-procurement time
always less than 24 h (13±6 h [4 to 24, 12]). Handling of the
donor  tissues  adhered  to  the  tenets  of  the  Declaration  of
Helsinki of 1975 and its 1983 revision in protecting donor
confidentiality.
Primary endothelial cell cultures: Using eight OC corneas
from  the  group  described  above,  ECs  were  isolated  and
cultured  according  to  protocols  published  elsewhere  [8].
Briefly, Descemet’s membrane with the attached ECs was
retrieved under a dissecting microscope, and incubated in 0.2
mg/ml  ethylenediaminetetraacetic  acid  (EDTA)  in  Hanks’
balanced salt solution (Eurobio), pH 7.4, for 1 h at 37 °C. After
centrifugation,  cells  were  resuspended  in  OPTIMEM-1
(Invitrogen  Life  technologies,  St-Aubin,  France)
supplemented with 8% fetal bovine serum (Eurobio), 40 ng/
ml of fibroblast growth factor, 5 ng/ml of epidermal growth
factor,  20  ng/ml  of  nerve  growth  factor  (the  three  from
Invitrogen), 20 mg/ml of ascorbic acid, 0.005% human lipids,
200 μg/l of calcium chloride, 0.08% chondroitin sulfate, 1%
RPMI-1640  multiple  vitamin  solution,  and  50  μg/ml
gentamicin (the last six from Sigma, St Quentin Fallavier,
France). Cells were incubated in six-well tissue culture plates
at 37 °C in a 5% carbon dioxide humidified atmosphere.
Medium was changed every other day. After primary cultures
reached confluence, cells were transferred to a non-precoated
T25 flask and subcultured until confluence. Then, 2000 cells
per well were seeded in non-precoated 96-well tissue culture
plates and cultured until subconfluence before being used for
ICC. These cultures were used as controls (see below).
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3496Study design: The work comprised two steps. First, we studied
whether a universal corneal preparation existed for IL in ECs
of flat-mounted corneas. We therefore chose four proteins
known  to  be  expressed  by  ECs  independently  of  their
proliferative  status  and  localized  in  four  different  cell
compartments. They were either perfectly characterized in
human ECs or ubiquitous proteins: (1) zonula occludens-1
(ZO-1) is a peripheral membrane protein associated with tight
junctions  [16];  (2)  actin  is  one  of  the  most  conserved
cytoplasmic proteins in eukaryotes and is distributed in linear
circumferential strands that form a hexagonal belt beneath
plasmic membrane in ECs [17]; (3) heterogeneous nuclear
ribonucleoprotein L (hnRNP L) is present in the nucleoplasm
as part of the hnRNP complexes that play a major role in the
formation, packaging, processing, and function of mRNA; (4)
bound with DNA, histone H3 is one of the basic nuclear
proteins  responsible  for  the  nucleosome  structure  of
chromosomal fibers in eukaryotes.
Considering  the  large  number  of  fixatives  and  AR
methods to assess, a systematic experiment matrix was built
to  minimize  the  number  of  human  corneas  necessary.
Fixatives and AR were chosen from the general histology and
cytology literature [18,19] as well as from current laboratory
practices.  They  were  classified  as  shown  in  Table  1.  To
increase the number of experiments while minimizing the
number of human corneas necessary, each cornea was cut into
eight pie-shaped wedges before or after fixation. Fixatives
were then successively assessed and preselected once correct
localization seemed to be achieved. Also to reduce the number
of corneas necessary, secondary controls and labeling controls
(see  below)  were  done  only  once  a  protocol  had  been
preselected.  When  labeling  of  ECs  and  positives  controls
seemed specific in terms of localization but faint and/or non-
homogeneous  (not  all  cells),  AR  methods  were  assessed
successively with the preselected fixative. In case of complete
negativity  for  all  fixation  protocols,  AR  methods  were
assessed  only  with  0.5%  formaldehyde  fixation  (which,
during the previous experiments in the study, had proved to
be the most efficient fixative overall).
Second, we applied the previously optimized protocols to
9 proteins involved in cell cycle: three proteins known as
proliferation markers (Ki67, proliferating cell nuclear antigen
[PCNA],  and  mini  chromosome  maintenance  protein  2
[MCM2]); five proteins involved in controlling cell cycle
phase G1 (cyclin D1, cyclin E, p16INK4a (p16), p21WAF1/Cip1
(p21), and p27Kip1 (p27)); and cyclin A for the S phase. All had
previously been studied in human corneas, but only Ki67 and
MCM2 on flat-mounted whole corneas. Protocols selected
after step one were applied to each of the 9 target proteins. If
staining  proved  unsatisfactory,  the  systematic  selection
process  was  applied  from  the  beginning  as  in  step  one,
excluding the fixatives and AR methods that consistenly had
negative results during step one.
Immunolocalization on flat-mounted whole corneas: Corneas
were rinsed in PBS before fixation. All tissues were fixed
immediately after retrieval or after being removed from OC
medium,  as  a  delay  between  retrieval  and  fixation  is
detrimental for immunostaining results [11]. To increase the
number of experiments, each cornea was cut into eight pie-
shaped wedges before or after fixation, but we occasionally
TABLE 1. FIXATION PROTOCOLS AND ANTIGEN RETRIEVAL METHODS ASSESSED ON WHOLE CORNEAS.
Number Fixation protocols
1 4% formaldehyde*, in PBS, pH 7.45 30 min at 4 °C
2 0.5% formaldehyde*, in PBS, pH 7.45 30 min at 4 °C
3 4% formaldehyde*, in PBS, pH 7.45 30 min at RT
4 0.5% formaldehyde*, in PBS, pH 7.45 30 min at RT
5 100% methanol 30 min at −20 °C
6 100% methanol 30 min at RT
7 100% acetone 30 min at −20 °C
8 100% acetone/100% methanol (1:1 v/v) 30 min at −20 °C
9 100% acetone/100% methanol (1:1 v/v) 30 min at RT
10 Carnoy I** 30 min at −20 °C
11 Carnoy I** 30 min at RT
12 Bouin modified*** 45 min at RT
13 0.5% Zn(OAc)2 + 0.5% ZnCl2 + 0.05% Ca(OAc)2 in 0.1M Tris base buffer 45 min at RT (Tris-Zinc)
14 HgCl2 6 g in formalin (37%–40%) 10 ml + distilled water 90 ml 45 min at RT
15 ZnCl2 0.16 g + PFA 4 g + NaCl 5 g in distilled water 100 ml 45 min at RT
Number Antigen retrieval methods
1 0.1 M citrate buffer pH 6, 4 h at 55 °C§
2 0.01 M EDTA buffer pH 10, 4 h at 55 °C§
3 0.1% trypsin in PBS, 5 min at 37 °C
4 4 M urea in water, 4 h at RT
5 0.5% sodium dodecyl sulfate in water, 5 min at RT
PBS phosphate buffer saline; RT room temperature; * always made fresh from paraformaldehyde; **100% ethanol/100% acetic
acid (3:1 v/v); ***75 ml picric acid saturated in water + 25 ml 4% PFA+5 ml acetic acid; § the highest temperature that did not
induce shrinking of fixed corneas.
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3497verified that the same results were observed for entire corneas
(data not shown) to eliminate artifacts caused by the cut and
border effects. Cell membranes were permeabilized by 1%
Triton x-100 in PBS for 5 min at room temperature (RT) after
fixation. This step was omitted when methanol, acetone or
SDS was used, as they alter lipids by themselves. AR methods
were then applied each time necessary (for details, see below).
The  non-specific  binding  sites  were  then  saturated  by
incubation with goat serum for 30 min at 37 °C. Primary and
secondary  antibodies  were  diluted  in  PBS  containing  2%
bovine serum albumin (BSA) and 2% goat serum. Primary
antibodies were incubated for 1 h at 37 °C. Corneal pieces
were totally immersed in 100 µl of this solution in eppendorf
microtubes to expose both endothelial and epithelial surfaces.
Incubation with secondary antibodies diluted 1:500 in PBS
containing 2% BSA and 2% goat serum was done for 45 min
at 37 °C. Nuclei were finally counterstained with Hoechst
33342 (Sigma) 10 µg/ml in PBS at RT for 2 min. Three rinses
in PBS were performed between all steps, except between
saturation of non-specific protein binding sites and incubation
with primary antibody. The corneal piece was finally placed
on a glass slide, covered with PBS and gently flattened using
a large glass coverslip retained by adhesive tape. Experiments
were  done  at  RT  unless  otherwise  stated.  Images  were
captured  by  a  fluorescence  inverted  microscope  IX81
(Olympus, Tokyo, Japan) equipped with the Cell^P imaging
software (Soft Imaging System GmbH, Munster, Germany).
This non-confocal microscope was chosen to obtain large-
field images able to tolerate the residual tridimensional (3D)
aspect of cell layers after flat-mounting.
The primary antibodies and their dilutions are listed in
Table 2. Whenever possible, they were chosen from among
antibodies validated for ICC by their manufacturers, which
seemed closest to our technique. Non-specific rabbit and/or
mouse IgG (ref 02–6102 and 02–6502, respectively; Zymed,
Carlsbad, CA,) were used as primary antibodies for negative
controls  (i.e.,  secondary  antibody  control  [20]).
Complementarily,  labeling  control  was  performed  by
omitting  primary  and  secondary  antibodies,  to  identify
potential autofluorescence. Secondary antibodies were Alexa
Fluor 488 goat anti-mouse IgG or/and Alexa Fluor 555 goat
anti-rabbit IgG (Invitrogen, Eugene, OR).
Controls for primary antibody specificity: To perform the
equivalent of a primary antibody control [20] as an indicator
for antibody specificity, immunostaining results in ECs of
flat-mounted corneas were compared with those of two types
of cells: epithelial cells of the same flat-mounted corneal
piece,  and  primary  cultures  of  ECs  studied  with  ICC.
Epithelial cells, known to form a highly proliferative layer
during OC [21], served as positive controls for the whole
process  with  predictable  patterns  of  expression  for
proliferation  markers  and  proteins  involved  in  cell  cycle
control. Primary EC cultures served as positive controls of the
same cell type, using conventional ICC techniques.
Immunocytochemistry  on  endothelial  cell  cultures:
Nonconfluent cell cultures were rinsed in PBS and fixed with
4%  formaldehyde  in  PBS  at  RT  for  15  min  without  any
TABLE 2. LIST OF PRIMARY ANTIBODIES.
Target proteins Animal source Clonality Laboratory Reference Dilution
ZO-1 mouse monoclonal Zymed, Carlsbad, CA 33–9100 1/200
actin rabbit polyclonal Sigma, Saint Louis,
MO
A2066 1/200
hnRNP L mouse monoclonal Abcam, Cambridge,
UK
ab6160 1/200
histone H3 rabbit polyclonal Abcam ab1791 1/200
Ki67 clone MIB-1 mouse monoclonal Dako, Glostrup,
Denmark
M7240 1/100
PCNA rabbit polyclonal Abcam ab18197 1/200
MCM-2 rabbit polyclonal Abcam ab31159 1/200
*cyclin D1 rabbit monoclonal Abcam ab16663 1/200
*cyclin D1 rabbit polyclonal Abcam ab31450 1/200
cyclin E rabbit polyclonal Abcam ab7959 1/100
cyclin A mouse monoclonal Abcam Ab38 1/200
p16INK4a rabbit polyclonal Interchim, Fremont,
CA
#RB-025-PABX 1/200
*p21Cip/WAF1 mouse monoclonal Cell Signaling,
Danvers, MA
#2946 1/200
*p21Cip/WAF1 rabbit polyclonal Santa Cruz, Santa Cruz,
CA
sc-397 1/200
*p21Cip/WAF1 mouse monoclonal Zymed, San Francisco,
CA
33–7000 1/200
p27kip1 mouse monoclonal Sigma P2092 1/200
          *For cyclin D1 and p21, different antibodies were tested because of initial negative results.
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3498subsequent AR, except for cyclin A which required the AR
with 0,5% SDS in water for 5 min at RT. Permeabilization,
saturation of the non-specific binding sites, immunoreactions,
and counterstaining were performed as described above for
flat-mounts.
Efficiency criterion: Protocols were deemed optimized once
labeling exhibited correct localization at light microscopic
level, with homogeneous staining, without zone effect (the
first  100  μm  near  the  cutting  edges  were  excluded),  and
absence  of  staining  in  secondary  antibody  and  labeling
controls. Defining correct localization was easy for ZO-1,
Actin, hnRNP L, and histone H3. For the 9 cell cycle-related
proteins, for which no absolute certainty existed, localization
was considered correct when it agreed with their fundamental
characteristics and by comparison with the staining patterns
in epithelial cells and EC cultures (both primary antibody
controls). Homogeneous staining was the last factor required.
In  case  of  equivalence  between  protocols  in  terms  of
specificity, the brightest staining was selected. Whatever the
result (positive or negative), each combination was assessed
on three independent corneas. The experiment was done twice
more  before  a  protocol  was  rated  “optimized.”
Immunostainings  were  evaluated  independently  by  two
observers experienced in immunohistochemical assessment
(Z.H., G.T.) on digital pictures blind to the preparation used.
Subcellular localization, extent, homogeneity and intensity
(signal/noise  ratio)  of  immunostainings  were  considered.
Intensity of staining was judged weak, moderate, or strong. In
case  of  disagreement,  a  third  judge  (P.G.)  reviewed  the
pictures.
RESULTS
Optimization of immulocalization:
ZO-1, actin, hnRNPL, and histone H3—Standard IHC
fixation  with  4%  formaldehyde  (at  4  °C  or  RT)  gave
unacceptable results for the four proteins: absence of staining
for actin, very weak staining or heterogeneous pattern for
hnRNPL and ZO-1, or aberrant pattern (cytoplasmic instead
of nuclear) for H3. These results clearly demonstrated the
need for optimization. Using systematic testing, we found
several protocols that provided the expected localization for
the four proteins in ECs and epithelial cells, at least for the
most superficial layers (Figure 2 and Table 3). Results were
similar for both fresh and stored corneas (data not shown).
Moreover, results of each protocol, whether correct or not,
were always coherent between endothelium and epithelium:
no discrepancy (correct localization on one side with aberrant
staining on the other) was ever observed, confirming that
epithelium can serve as a primary antibody control. Negative
controls (with irrelevant antibodies and without antibodies)
remained constantly unstained. Fixation in pure methanol at
RT for 30 min appeared the best compromise to localize the
four proteins present in four different cell compartments, even
if not optimal for both nuclear proteins. AR greatly improved
H3 labeling.
Cell cycle-related proteins—Methanol for 30 min at
RT, found to be the best compromise in the previous step, was
not able to provide correct IL for the 9 proteins of interest,
indicating that antibody/antigen specific preparations were
probably necessary. Selected protocols are summarized in
Table  4.  There  was  no  ubiquitous  protocol  but  0.5%
formaldehyde alone was nevertheless usable for eight out of
nine cases, even if it was not optimal for four antibodies.
Notably, 0.5% formaldehyde alone was the only solution for
p21  and  p27  antibodies.  AR  strongly  improved
immunostaining quality (brightness and contrast) for PCNA,
cyclin E, and p16. It was even the only efficient solution for
cyclin A. Each time AR was necessary, it increased the risk
of EC detachment from Descemet membrane, so fixation time
was increased to 1 h to reduce this risk. As for ZO-1, Actin,
hnRNPL, and H3, results of all assessed combinations were
coherent between endothelial and epithelial cells of the same
cornea. As we could not obtain cyclin D1 or p21 staining in
ECs  of  flat-mounts  with  any  of  the  protocols  with  the
antibodies initially chosen, we assessed other antibodies using
the same procedure. Staining of positive controls was always
comparable between antibodies of the same target, using the
same protocols.
For ICC on primary EC cultures, 4% formaldehyde gave
reproducible correct IL for all proteins tested except for cyclin
A, which required additional AR with 0.5% SDS in water for
5 min at RT.
Summary  of  optimized  protocols  obtained  on  flat-
mounted whole corneas—Fixation with 0.5% formaldehyde
at RT with or without AR was efficient for 12 antibodies/
proteins out of 13, and considered as the best protocol for 10
out of them. Fixation with 0.5% formaldehyde alone for 30
min was efficient for 10 antibodies and considered as the best
protocol for five antibodies. Two AR methods combined with
0.5% formaldehyde improved detection for four antibodies:
0.5% SDS in water at RT for 5 min and 0.1% trypsin in PBS
at 37 °C for 5 min. Fixation with methanol alone was efficient
for six antibodies, and considered as the best protocol for two
antibodies.
Cell cycle protein expression:
Proliferation  markers—We  were  first  interested  in
analyzing  the  presence  and  localization  of  proliferation
markers  widely  used  in  clinical  histological  studies,  and
selected Ki67, PCNA and MCM2 (Figure 3 and Table 5). Ki67
positive cells were not detected in ECs of whole corneas. A
few positive cells were observed in the epithelium of fresh
corneas  with  death-to-procurement  time  under  24  h.  The
number of Ki67 positive cells always increased dramatically
in the epithelium of stored corneas. In in vitro ECs, Ki67
positive cells were numerous. Staining pattern characteristics
of Ki67 were clearly visible in nuclei. Occasionally epithelial
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3499Figure 2. Optimization of immunolocalization of ZO-1, actin, hnRNP L, and histone H3 in endothelial cells on flat-mounted whole human
corneas. Only the best combination is shown in the first line, compared with the 4% formaldehyde usually considered as the gold standard in
immunohisto- and cytochemistry. Original magnification 40×. Bar 10 μm.
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3500mitosis  were  observed,  confirming  completion  of  the  cell
cycle.
PCNA was essentially detected with an invariable signal
in the nucleus of all ECs on both fresh and stored corneas and
of  in  vitro  ECs.  Both  nuclear  and  weak  cytoplasmic
expression was found in a few epithelial cells of fresh corneas.
After  storage,  PCNA  was  detected  in  the  nucleus  of  all
epithelial cells.
The staining pattern of MCM2 differed totally in ECs and
epithelial cells. It was mainly cytoplasmic in most of ECs of
both fresh and stored corneas. It filled the lateral expansions
of cytoplasm located at the basal Descemetic pole of ECs,
giving a characteristic hairy aspect. MCM2 was preferentially
detected  in  the  nucleus  of  in  vitro  ECs,  but  cytoplasmic
staining was also observed. In the epithelium, MCM2 was
exclusively found in the nucleus of only a few cells on fresh
corneas but in those of almost all cells on stored corneas.
G1  and  S  phase  markers—We  next  analyzed  the
presence  and  localization  of  cyclins  involved  in  the  G1/S
transition  and  S-phase,  cyclin  D1,  cyclin  E  and  cyclin  A
(Figure 4 and Table 5). The expression pattern of both cyclin
D1 and cyclin E also differed totally in ECs and epithelial
cells.  Surprisingly,  with  the  monoclonal  rabbit  antibody
(ab16663; Abcam) no staining was observed in ECs whatever
the sample preparation. With the polyclonal rabbit antibody
(ab31450;  Abcam)  cyclin  D1  was  absent  or  had  dim
paranuclear staining in fresh corneas’ ECs, which increased,
after storage. Nuclear and weak cytoplasmic staining was
TABLE 3. OPTIMIZATION OF IMMUNOLOCALIZATION OF ZO-1, ACTIN, HNRNP L, AND HISTONE H3 IN ENDOTHELIAL CELLS ON FLAT-MOUNTED WHOLE HUMAN CORNEAS.
Target protein Classification Selected protocols
ZO-1 best methanol at −20 °C
  second choice methanol at RT; 0.5% formaldehyde at RT; Carnoy I at −20 °C
Actin best methanol at RT
  second choice Carnoy I at −20 °C
hnRNP L best 0.5% formaldehyde at RT
  second choice methanol at RT
histone H3 best 0.5% formaldehyde + AR with 0.5% SDS in water 5 min at RT *
  second choice methanol at RT
        * SDS: Sodium dodecyl sulfate. In these cases fixation was prolonged during 1 h to avoid endothelial cell detachment induced
        by SDS with short time fixation. For all other cases, fixation during 30 min.
TABLE 4. OPTIMIZATION OF IMMUNOLOCALIZATION FOR CELL CYCLE-RELATED PROTEINS IN ENDOTHELIAL CELLS ON FLAT- MOUNTED WHOLE HUMAN
CORNEAS.
Target protein Classification Selected protocols
Ki67 best 0.5% formaldehyde
  alternatives 4% formaldehyde; methanol
PCNA best 0.5% formaldehyde 60 min at RT + AR with 0.5% SDS 5 min at
RT
  alternatives 0.5% formaldehyde; methanol
MCM-2 best 0.5% formaldehyde
  alternatives /
cyclin D1 (abcam 31450) best Carnoy I at −20 °C
  alternatives 0.5% formaldehyde
cyclin E best 0.5% formaldehyde 60 min at RT + AR with 0.1% trypsin 5 min
at 37 °C
  alternatives 0.5% formaldehyde
cyclin A best 0.5% formaldehyde 60 min at RT + AR with 0.5% SDS 5 min at
RT
  alternatives /
P16 best 0.5% formaldehyde for 60 min at RT + AR with 0.5% SDS 5 min
at RT
  alternatives 0.5% formaldehyde
P21 (cell signaling #2946) best 0.5% formaldehyde
  alternatives /
P27 best 0.5% formaldehyde
  alternatives /
          Fixation was at RT during 30 min, unless otherwise stated. /=absence of second choice protocol.
Molecular Vision 2011; 17:3494-3511 <http://www.molvis.org/molvis/v17/a376> © 2011 Molecular Vision
3501Figure 3. Optimized immunolocalization of proliferation markers in endothelial cells on flat-mounted whole human corneas. Only the best
combination of fixative and epitope retrieval is shown for each antibody (see Table 4). Original magnification 40× except insets (96×). Bar
10 μm.
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3502found in in vitro ECs. In epithelium, with both antibodies,
cytoplasmic localization was observed on fresh corneas. After
storage, cyclin D1 had a predominant nuclear localization in
almost all epithelial cells.
Cyclin E was homogeneously detected in the nucleus of
all ECs on both fresh and OC corneas but exclusively in the
cytoplasm of in vitro ECs. In contrast, in the epithelium it was
heterogeneously detected either in the cytoplasm, the nucleus
or both and OC seemed to increase nuclear staining.
Cyclin A was found in almost all ECs on both fresh and
stored corneas with a cytoplasmic localization. Hexagonal
cytoplasmic patterns were observed in ECs on fresh corneas.
Nuclear staining was predominant in in vitro ECs. In the
epithelium,  cyclin  A  was  mostly  cytoplasmic  on  fresh
corneas, but accumulated in the nucleus in numerous cells
after storage.
Cell cycle inhibitors—We next analyzed the presence
and localization of cyclin-dependent kinase inhibitors, p16,
p21, and p27 (Figure 5 and Table 5).
p16, a Cdk4 and Cdk6 inhibitor that play a role at the
G1/S transistion was detected homogeneously in the nucleus
of all ECs of both fresh and stored corneas. Weak cytoplasmic
or both nuclear and cytoplasmic staining was observed in in
vitro ECs as well as in epithelial cells on fresh corneas. After
storage, the nuclear accumulation of p16 disappeared in all
epithelial cells.
We found no p21, a Cdk1, and Cdk2 inhibitor, in ECs of
fresh  or  stored  corneas,  with  any  of  the  three  antibodies
assessed under the various sample preparations. Nevertheless,
p21 was found in the nucleus of in vitro ECs in an identical
manner with all three antibodies, but the best results were
obtained with the mouse monoclonal antibody (#2946; Cell
Signaling). In epithelial cells, p21 was predominantly found
in the cytoplasm of fresh corneas, with a particular granular
pattern in the most superficial cells (especially with death-to-
procurement  time  below  24  h).  After  storage,  p21  was
detected exclusively in the nucleus of epithelial cells.
p27, also a Cdk1 and Cdk2 inhibitor, was homogeneously
detected in the nucleus of all ECs of both fresh and stored
corneas. It was detected in both the nucleus and cytoplasm of
in vitro ECs. In epithelial cells on fresh corneas, p27 was
heterogeneously  detected  in  cytoplasm,  nuclei  or  both.
Similarly to p21, cytoplasmic localization had a particular
granular pattern in epithelial cells on fresh corneas with a short
death-to-procurement  time.  After  storage,  p27  staining
dramatically decreased and concerned only a few nuclei.
DISCUSSION
Through systematic testing, on a very large series of human
corneas, of most of the fixatives and AR methods that we felt
were applicable to the cornea, we determined the optimal
preparations for several cell cycle control proteins.
Optimization  of  immunolocalization  on  flat-mounted
whole corneas: Endothelial immunostaining on flat-mounted
corneas  offers  many  advantages  over  that  done  on
conventional  histological  cross-sections,  but  requires
adaptation of the usual protocols due to the specificities of the
endothelium. IL on flat-mounted whole corneas (intact cell
monolayer on intact tissue) possesses the characteristics of
both IHC (tissue) and ICC (intact cells). Contrary to IHC,
where the content of cross-sectioned cells is easily visible,
membrane  permeabilization  is  required  for  intact  ECs  of
whole flat-mounted corneas to diffuse bulky antibodies and
secondary labels. This may be achieved by certain fixatives
alone  (altering  lipids)  or  requires  an  additional  step  of
membrane  permeabilization.  Moreover,  while  dangers  of
over- [11] and underfixation [22] have been highlighted for
IHC on formalin-fixed tissue, they have not been discussed
for  a  superficial  cell  layer  such  as  ECs.  These  form  a
monolayer of cells that are strongly joined together but adhere
TABLE 5. SUBCELLULAR LOCALIZATION OF THE PROTEINS INVOLVED IN THE CELL CYCLE IN ENDOTHELIAL CELLS AND IN BOTH
CONTROLS (IN VITRO ENDOTHELIAL CELLS AND EPITHELIAL CELLS OF WHOLE FLAT-MOUNTED CORNEAS).
  Endothelial cells Epithelial cells
Target protein  Fresh Stored In vitro cultures Fresh Stored
Ki67 A A N N N
PCNA N N N, N+C N, C, N+C N
MCM2 C C N, N+C N N
cyclin D1 C C N, N+C C, N+C N
cyclin E N N C N, C, N+C N, C, N+C
cyclin A C C N, N+C C N, C, N+C
p16 N N N, C, N+C N, C, N/C C
p21 A A N N, C N
p27 N N N, C, N+C N, C, N+C N, C, N+C
           A: absence of detection; N: nuclear; C: cytoplasmic, N+C: both nuclear and cytoplasmic.
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3503Figure 4. Optimized immunolocalization of cyclins D1, E, and A in endothelial cells on flat-mounted whole human corneas. Only the best
combination of fixative and epitope retrieval is shown for each antibody (see Table 4). Original magnification 40× except insets (96×). Bar
10 μm.
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3504Figure 5. Optimized immunolocalization of three cyclin dependent kinase inhibitors p16, p21, and p27 in endothelial cells on flat-mounted
whole human corneas. Only the best combination of fixative and epitope retrieval is shown for each antibody (see Table 4). Original
magnification 40× except insets (96×). Bar 10 μm.
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3505relatively  poorly  to  their  Descemet  membrane.  They
withstand certain reagents better than cells cultured in vitro
on slides, but less well than cells nested in tissue mass. To
preserve the integrity of this fragile monolayer, we found a
compromise between tissue fixation, permeabilisation of cell
membranes to give access to antibodies, and restricted use of
AR techniques, which, though useful, carry a high risk of cell
detachment or tissue retraction, especially those involving
high  temperature.  In  particular,  we  showed  that  the  most
common fixation method, 4% formaldehyde, did not achieve
correct  localization  of  most  of  the  proteins  studied,
irrespective of their cell compartment, probably because there
is high and rapid cross-linking of antigenic targets in the
directly acccesible superficial cells [23].
We did not find a universal protocol able to satisfactorily
reveal all antigens in ECs. Nevertheless, we selected several
efficient  solutions  that  could  help  standardize
immunostaining  of  ECs  and  facilitate  inter-laboratory
comparisons. Notably, 0.5% formaldehyde with or without
AR or methanol at RT for 30 min are the three simplest and
most  efficient  protocols,  as  all  antigens  tested  seemed
correctly localized by one or another of the protocols. The
efficacy of a low concentration of formaldehyde had been
described for immunostaining on cytologic preparations [18].
It  seems  therefore  that  overfixing  was  the  main  obstacle
during IL on ECs of flat-mounted corneas.
Interestingly,  AR  with  SDS  greatly  improved
immunolocalization of the three nuclear proteins H3, PCNA,
and  P16.  SDS  is  a  detergent,  used  in  the  SDS–PAGE
technique and DNA extraction, because it can disrupt non-
covalent bonds between proteins, and between proteins and
DNA, a property also useful for AR. Histone H3 is one of the
proteic  constituents  of  chromatin,  while  PCNA  can  be
presented in chromatin-associated form [24], and P16 can
directly interact with PCNA in nuclei [25]. Our data suggest
that  SDS  enhanced  staining  quality  after  formaldehyde
fixation by unmasking the epitopic fragments of histone H3
or  PCNA,  which  are  probably  hidden  by  their  physical
interaction with DNA.
We  used  two  complementary  positive  controls  for
primary antibodies [20]: epithelial cells of the same cornea,
observed at the same time on the opposite side of the flat-
mount, and human corneal EC in primary cultures. Both were
useful to distinguish negative staining of EC due to absence
of expression or due to an unadapted protocol. Observation of
the epithelial layer was particularly useful because it was
submitted to exactly the same preparation as EC, as corneal
pieces were entirely immersed in the different solutions. The
difficulty  relating  to  the  multilayered  organization  of  the
corneal  epithelium  was  taken  into  account  during
interpretation. Use of a non-confocal microscope was in this
respect an advantage, as we could observe two or three layers
of cells at the same time. In vitro ECs did not behave in the
same  way:  stronger  fixation  (4%  formalhedyde)  was
necessary to avoid cell detachment during the rest of the
process. Why 4% formaldehyde allows perfect localization in
in vitro ECs and not in situ, where a lesser concentration
(0.5%) is far more appropriate, remains unclear. The surface
coating  layer  present  in  vivo  on  top  of  the  EC  plasma
membrane, comprising, among other molecules, membrane
proteins, proteoglycans and glycoproteins [26] may form after
4% formaldehyde fixation, a layer relatively impermeable to
most of the antibodies.
Expression of the ten cell cycle proteins: To the best of
our  knowledge,  investigation  of  a  large  range  of  proteins
involved in the cell cycle had never been performed in fresh
human  corneas  fixed  immediately  after  procurement  in
donors, without being stored before study. Only Ki67 (clone
SP6; Labvision, Fremount, CA) and PCNA (clone PC 10;
Dako, Glostrup, Denmark) had been studied on 4% PFA-fixed
cross-sections of fresh corneas, but with extended postmortem
time (29 to 163 h) [27] and only PCNA on cross-sections of
fresh  corneas  (postmortem  time  not  available)  [28].
Modifications in protein expression profile induced by any
storage medium (4 °C or OC), even when storage is short,
cannot be ruled out. By avoiding this storage time, one is sure
to stay as close as possible to physiologic conditions, except
for the postmortem metabolic changes that inevitably also
occur. Only the study of corneas retrieved from enucleated
globes  for  posterior  tumor  would  ensure  true  physiologic
conditions, but these cases are fortunately scarce and do not
provide a sufficient source of human tissue.
We compared fresh corneas with similar corneas after
several  weeks  of  storage  in  OC  and  highlighted  several
differences never described before. Conventional OC media
are  derived  from  Dulbecco’s  modified  Eagles  minimum
essential medium supplemented with 2% FCS necessary to
ensure EC survival up to 5 weeks. They also stimulate wound
healing by cell migration and enlargement [29] but are not
known to stimulate EC proliferation. Only in a very specific
OC medium containing 8% FCS has EC proliferation been
described in situ [27,28]. On the contrary, non-confluent in
vitro  cultures  of  human  adult  ECs  contain  numerous
proliferating cells, explaining a profile totally different from
EC in situ. Overall, the profile of cultured ECs is very similar
to that of epithelial cells after OC, both being used as primary
antibody controls [20]. During OC, the epithelial layer is
highly activated and may completely regenerate even after
long death-to-retrieval time [21]. Nevertheless, although cells
proliferate,  the  number  of  cell  layers  gradually  decreased
during OC [30], explaining why we observed mainly basal
cells where higher proliferative activity occurs. In this article,
we have described both a method for systematically assessing
antibodies  on  whole  mount  en  face  cornea,  and  staining
patterns for a set of antibodies directed against cell-cycle
proteins. We are well aware that the use of a single technique
does not allow for definitive interpretation of data, and that
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3506additional primary antibody controls should be added. Several
methods could be applicable to ECs, such as immunostaining
after  knocking  down  the  specific  protein  expression  with
siRNA, a combination of immunostaining and fluorescent in
situ hybridization, or immunoblots, and will be the subjects
for  future  studies,  as  they  require  substantial  technical
developments. The following interpretation of our data should
therefore be seen as open avenues for further investigations.
The Ki67 antibody was originally identified as a reliable
marker for a nuclear antigen present in proliferating cells,
from late G1 to M phase, and is therefore approved as a
ubiquitous proliferation marker [31,32]. As expected, no Ki67
staining was observed in ECs of fresh and stored corneas,
whereas it was abundant in epithelial cells and in vitro ECs,
two situations where cells proliferate. Ki67 positive ECs and
even mitosis have previously been described on wholemounts
of  human  corneas,  with  clone  MIB-1  by  Zymed  (San
Francisco, CA), in experiments of wound healing in presence
of 10% FBS and growth factors [33]. In this study, corneal
pieces  were  fixed  for  10  min  in  ice-cold  methanol  and
incubated in 1% Triton X-100 to permeabilize the cells. We
also found methanol to be a possible fixative for Ki67, but
0.5% formaldehyde without subsequent cell permeabilization
seemed better. From the Ki67 pattern, it appears that whereas
the epithelium is highly proliferative in OC, the endothelium
is devoid of proliferating cells either in fresh or in stored
corneas.
PCNA is another proliferation marker in a wide variety
of cell types whose accumulation in the nucleus begins early
in the G1 phase. It is a cofactor of DNA polymerase delta
[34] but also has numerous other functions in response to
DNA damage, cell cycle control, chromatin assembly and
cohesion, and in other functions [24]. In ECs, PCNA had only
been studied on cross-sections [27,28]: PCNA positive ECs
were found in long-term OC corneas but not in fresh corneas
[28]. On the contrary, we observed homogeneous nuclear
PCNA  staining  in  all  ECs  of  fresh  and  stored  corneas,
indicating that PCNA may not be considered as a proliferation
marker in this population, whereas staining was more typical
in epithelial cells with an increase of nuclear staining after OC.
The role of PCNA in ECs remains however to be determined
but could be related to nuclear oxidative DNA damage that
accumulates in ECs throughout their life [35]. Furthermore,
there  could  be  a  relationship  with  the  ubiquitous  nuclear
localization of p16 that we found in ECs of fresh and stored
corneas, as p16 can interact directly with PCNA and inhibit
DNA polymerase delta activity [25].
MCM2–7 are highly conserved proteins, which form a
hexameric  complex  with  replicative  helicase  activity  [36]
involved in the regulation of DNA duplication [37]. MCM2
is undetectable in G0, and accumulates in the nucleus during
G1, peaking on S-phase entry [38], which explains its role as
a proliferation marker. MCM2 is then eliminated from the
nucleus during the S phase. In ECs in situ, we found no nuclear
MCM2 but dense fibrillary cytoplasmic staining, unmodified
after storage. The irregular shape of ECs was due simply to
the filling by fluorescent markers of the irregular basolateral
cytoplasmic  expansions  previously  described  [39,40].  In
contrast, MCM2 was always detected exclusively in nuclei of
the proliferative epithelial cells and preferentially in nuclei of
in vitro ECs. Incidentally, a similar pattern in cultured ECs
had  already  been  described  [41].  Interestingly,  the
sequestration of MCM proteins in cytoplasm and therefore the
inability of MCM to initiate DNA synthesis is one of the
mechanisms by which progesterone inhibits estrogen-induced
uterine  epithelial  cell  proliferation  [42].  We  propose  that
MCM2 sequestration in ECs could play a role in G1-phase
arrest. Nuclear localization of MCM2 had previously been
described in nuclei of ECs using corneal pieces fixed for 10
min in ice-cold methanol and incubated in 1% Triton X-100
to permeabilize the cells (MCM2 antibody; BD PharMingen,
San Diego, CA) [7]. In the latter experiments, designed to
analyze  proliferation  in  response  to  a  calibrated  wound,
corneas  initially  stored  at  4  °C  for  several  days  were
subsequently  incubated  at  37  °C  in  culture  medium
supplemented  with  8%  FCS  and  various  growth  factors.
MCM2 positive nuclei were observed between 36 to 72 h after
wounding and only in ECs close to the wound. These results
do not contradict our own, since our OC conditions differ
greatly from these proliferation-promoting conditions. In our
hands, only 0.5% formaldehyde was able to make the Abcam
MCM2  antibody  react.  Methanol  did  not  help  reveal
cytoplasmic MCM2.
Cyclins  and  their  catalytic  partner  cyclin-dependent
kinases (CDKs), regulate cell cycle progression in eukaryotes.
The three D cyclins (D1, D2, D3) accumulate during G1 phase
in  response  to  mitogenic  stimulation,  and  assemble  with
CDK4 and 6. Cyclin D1 is an important actor in G1 to S
progression by inactivating the cell cycle-inhibiting functions
of  the  retinoblastoma  protein  through  phosphorylation.  In
addition, cyclin D/CDK complexes sequester CDK inhibitors
such as p21 and p27. Nevertheless, once assembled with CDK
within the cytoplasm, complexes need to be imported into the
nucleus to be active. For example, it has been demonstrated
that the prevention of their nuclear import plays a critical role
in  the  maintenance  of  cardiomyocytes  in  their  non-
proliferative state acquired soon after birth [43]. It has also
been shown that postmitotic normal neurons lose their ability
to import cyclin D/CDK complexes into the nucleus and that
this ectopic cytoplasmic localization plays a role in neuron
survival [44]. Aside from its role in cell cycle control, cyclin
D1  also  possesses  other  CDK-independent  functions  [45]
such  as  chromatin  remodelling,  cell  metabolism,  and  cell
migration  [46].  The  exclusive  cytoplasmic  localization  of
cyclin  D1  that  we  found  in  all  ECs,  without  nuclear
translocation after storage whereas it localized in nuclei of
proliferating in vitro ECs and in basal epithelial cells after
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that cyclin D1 has CDK-independent functions in ECs. It also
suggests that ECs might have passed the restriction point (after
which, in a normal cell cycle, cyclin D1 is exported from the
nucleus).
Cyclin E/CDK2 complexes act normally after cyclin D/
CDK4–6 complexes during G1 phase. Their activity rises in
late G1 phase, peaks at G1/S transition, and declines quickly
during  the  S  phase  [47,48].  Nevertheless,  cyclin  E
accumulation in nuclei with inactive cyclinE/cdk2 complexes
is compatible with arrest in the G1 phase related to senescence
[49] and when overexpressed in nontransformed HC11 mouse
mammary epithelial cell line, cyclin E localizes exclusively
in nuclei, induces an increase in p27 expression, and inhibits
cell  proliferation  [50].  Our  results,  showing  constant
localization of cyclin E in nuclei of all ECs in fresh and stored
corneas,  are  therefore  compatible  with  non-proliferative
status, and suggest again that ECs in situ might be arrested
after the restriction point and before the entry in S-phase. In
epithelial  cells,  staining  was  heterogeneous  and
nucleocytoplasmic  in  most  cells  in  fresh  corneas  with  a
predominant nuclear translocation after storage, suggesting
progression through the cell cycle. In in vitro ECs cyclin E
was mostly localized in the cytoplasm, suggesting that they
crossed the restriction point of the cell cycle.
Cyclin A is nomally expressed from late G1 to late G2
phases. Cyclin A/CDK complexes have substrates in both the
nucleus  and  the  cytoplasm  and  shuttle  between  the  two
compartments [51]. It initially assembles with CDK2 to form
a complex imported in the nucleus, where it phosphorylates
nuclear  substrates  implicated  in  DNA  replication,  thus
promoting  progression  through  the  S  phase  [52].  In
proliferating epithelial cells and in vitro ECs, cyclin A is
mainly nuclear which is a hallmark of proliferating cells. We
found it exclusively expressed in the cytoplasm of ECs of
fresh and stored corneas, which again hints at cells having
passed the restriction point. It is possible that the cytoplasmic
retention of cyclin A hinders progression through S-phase. It
would  be  interesting  to  assess  cyclin  A/CDK  complexes
activity  in  ECs  in  situ,  as  cytoplasmic  substrates  of  the
complexes might play a role in ECs physiology.
Our results for cyclins D1, E and A in whole corneas were
consistent with the previous studies by Joyce et al. on cross-
sections of corneas from seven donors aged 6 weeks to 67
years and stored at 4 °C during 24 to 36 h (Antibodies from
Upstate  Biotechnology,  Lake  Placid,  NY)  [53,54].  Flat
mounts now allow clearer subcellular localization as well as
observation of a larger population of ECs.
We detected p16 in the nuclei of ECs of both fresh and
stored corneas. This is consistent with previous results of IHC
done  on  cross-sections  of  human  corneas,  although
subcellular localization was in either cytoplasm [54] or nuclei
[55,56] of ECs. P16 inhibits cyclin D/CDK4–6. It is thus
considered to have a pivotal role in G1-phase arrest of ECs and
stress-induced premature senescence [57]. Furthermore, p16
could interact directly with nuclear PCNA found in ECs and
inhibit DNA polymerase delta activity [25]. In epithelial cells,
cytoplasmic translocation occurred after OC, corresponding
to prominent proliferative status. In in vitro ECs, p16 was
found in both nuclei and cytoplasm, indicating cytoplasmic
translocation compatible with cell cycle progression.
We did not detect p21 in ECs of flat-mounted fresh or
OC-stored corneas despite systematic assessment of a wide
variety of fixatives and AR and the use of three antibodies.
P21 positivity in the nuclei of epithelial cells of the same
corneal piece and in in vitro ECs eliminates a false-negative
result in ECs. This apparently contradicts two previous studies
that used IHC on cross-sections of 4 °C stored human corneas.
In  one  case,  a  p21  antibody  C-19  from  Santa  Cruz
Biotechnology was used on six corneas stored at 4 °C and
confirmed by western blots of proteins extracted from in vitro
EC cultures [55]. In the second case, a p21 mouse monoclonal
antibody from Lab Vision Corp (Fremont, CA) was used on
four  corneoscleral  rims  left  off  after  corneal  graft  and
confirmed with quantitative RT–PCR on RNA extracted from
other corneo-scleral rims [56]. Both found nuclear staining for
p21. It remains unclear why we did not reveal p21 in ECs in
flat-mounted cornea methods. It is possible that fresh and OC
corneas  with  preserved  metabolic  activities  may  behave
differently from corneas stored for several days at 4 °C. As
we found that in vitro EC cultures expressed p21 in nuclei, it
is not surprising that WB was found positive by Enomoto et
al. [55]. Moreover, the presence of p21 transcripts in ECs from
whole corneas is not incompatible with post-transcriptional
alterations  resulting  in  absence  of  protein  expression.  At
present, no other study has revealed p21 expression using
immunolocalization in ECs. A direct comparison of paired
corneas, one stored at 4 °C and the other either studied fresh
or after OC, seems necessary to answer the question. We
detected p21 in the nucleus of proliferative cells: epithelial
cells of OC corneas and in vitro EC cultures. P21 is one of the
main CKIs implicated in late G1-phase arrest by inhibiting
cyclin E/CDK2 complexes [58], but p21 can also contribute
to initial G1 progression by promoting the nuclear import of
cyclin  D/CDK4–6  complexes  [59]  and  by  preventing  the
nuclear export of cyclin D [60].
P27,  another  CIP/KIP  family  member,  also  strongly
inhibits cyclin E/CDK2 complexes and arrests the cell cycle
in G1 [61]. It is implicated in cell cycle arrest triggered by
contact  inhibition  and  TGFβ  [62].  Its  role  has  been
demonstrated in rats [63] and the protein has been detected in
nuclei of ECs on cross-sections of two corneas from donors
aged 18 and 74 years [55] and in one cornea from a 54-year-
old donor [56]. The three corneas had been stored shortly at
4 °C beforehand. In our study, in epithelial cells, the near-
complete disappearance of p27 after OC strongly suggests cell
cycle progression as, at the end of the G1 phase, cyclin E/
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and  cytoplasm)  phosphorylate  p27  that  is  subsequently
ubiquitinated by Skp1/Skp2 and degraded by the proteasome
[64]. In cultured ECs, p27 in both nuclei and cytoplasm also
suggests possible progression beyond the restriction point.
In conclusion, IL on flat-mounted whole corneas seems
possible  for  a  large  number  of  proteins,  provided  that
substantial  adaptations  in  corneal  fixation  and  further
processing are adopted. Continued efforts to refine methods
of antigen preservation or retrieval in human corneas will
ultimately  allow  standardization  of  IL  and  elimination  of
inter-laboratory  discrepancies  in  results,  thus  allowing
accurate research. 0.5% formaldehyde or methanol without
AR  should  be  recommended  as  first-line  fixatives  during
experimental  developments,  given  that  in  situ  ECs  seem
particularly sensitive to overfixation by aldehydes and that
AR  methods  often  harm  the  integrity  of  the  endothelial
monolayer. Conventional OC medium containing 2% FCS
does not modify the non-proliferative status of ECs, which is
compatible  with  G1-phase  arrest.  Nevertheless,  our  data
suggest that ECs are arrested after the restriction point in the
G1 phase. The role of MCM2 in cytoplasm, the subcellular
localization of cycle D1, and the absence of p21 are the main
characteristics  highlighted  by  our  optimized  protocols.
Further studies are necessary to explain these particularities
of fresh and OC-stored corneas.
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